Keywords: shire, 3rd-qtr, revenue, rises, posted, third-quarter, earnings
Shire's 3rd-qtr 2006 revenue rises 19%
Article | 06 November 2006
Shire posted third-quarter 2006 earnings ahead of expectations. The UK drugmaker made $449.4 million, up 19% on the comparable period last year, due ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
